These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 17303472)

  • 1. Novel anti-arrhythmic agents for the treatment of atrial fibrillation.
    Wettwer E; Christ T; Dobrev D; Ravens U
    Curr Opin Pharmacol; 2007 Apr; 7(2):214-8. PubMed ID: 17303472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling).
    Goette A; Bukowska A; Lendeckel U
    Curr Opin Pharmacol; 2007 Apr; 7(2):219-24. PubMed ID: 17276728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of atrial remodeling and clinical relevance.
    Nattel S; Shiroshita-Takeshita A; Cardin S; Pelletier P
    Curr Opin Cardiol; 2005 Jan; 20(1):21-5. PubMed ID: 15596955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
    Runge S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class 1 antiarrhythmic agents for therapy of atrial fibrillation.
    Podrid PJ
    Herz; 1993 Feb; 18(1):9-19. PubMed ID: 8454255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
    Burstein B; Nattel S
    J Am Coll Cardiol; 2008 Feb; 51(8):802-9. PubMed ID: 18294563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pharmacological therapies for atrial fibrillation.
    Bagwe S; Leonardi M; Bissett J
    Curr Opin Cardiol; 2007 Sep; 22(5):450-7. PubMed ID: 17762547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiological remodeling induced by atrial fibrillation. An experimental curiosity or major factor in atrial fibrillation in man?].
    Piot O; Paziaud O; Digeos S; Copie X; Lavergne T; Guize L; Le Heuzey JY
    Arch Mal Coeur Vaiss; 2000 Jul; 93(7):841-8. PubMed ID: 10975036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrical remodeling in atrial fibrillation.
    Dobrev D
    Herz; 2006 Apr; 31(2):108-12; quiz 142-3. PubMed ID: 16738832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Class III drugs on atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Piepoli M
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S109-20. PubMed ID: 9727685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pharmacological targets and treatments for atrial fibrillation.
    Carlsson L; Duker G; Jacobson I
    Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?
    Nattel S
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):885-6. PubMed ID: 15333079
    [No Abstract]   [Full Text] [Related]  

  • 18. New directions in antiarrhythmic drug therapy for atrial fibrillation.
    Heijman J; Voigt N; Dobrev D
    Future Cardiol; 2013 Jan; 9(1):71-88. PubMed ID: 23259476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrophysiologic and anatomic atrial remodeling: an atrial rhythmic cardiomyopathy].
    Davy JM; Beck L; Pons M; Piot C
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):39-45. PubMed ID: 10816800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial structural remodeling as an antiarrhythmic target.
    Burstein B; Nattel S
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.